Human glutathione-S-transferase pi potentiates the cysteine-protease activity of the Der p 1 allergen from house dust mite through a cysteine redox mechanism.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
09 2019
Historique:
received: 24 04 2019
revised: 30 05 2019
accepted: 10 06 2019
pubmed: 24 6 2019
medline: 29 2 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

Environmental proteases have been widely associated to the pathogenesis of allergic disorders. Der p 1, a cysteine-protease from house dust mite (HDM) Dermatophagoides pteronyssinus, constitutes one of the most clinically relevant indoor aeroallergens worldwide. Der p 1 protease activity depends on the redox status of its catalytic cysteine residue, which has to be in the reduced state to be active. So far, it is unknown whether Der p 1-protease activity could be regulated by host redox microenvironment once it reaches the lung epithelial lining fluid in addition to endogenous mite components. In this sense, Glutathione-S-transferase pi (GSTpi), an enzyme traditionally linked to phase II detoxification, is highly expressed in human lung epithelial cells, which represent the first line of defence against aeroallergens. Moreover, GSTpi is a generalist catalyst of protein S-glutathionylation reactions, and some polymorphic variants of this enzyme has been associated to the development of allergic asthma. Here, we showed that human GSTpi increased the cysteine-protease activity of Der p 1, while GSTmu (the isoenzyme produced by the mite) did not alter it. GSTpi induces the reduction of Cys residues in Der p 1, probably by rearranging its disulphide bridges. Furthermore, GSTpi was detected in the apical medium collected from human bronchial epithelial cell cultures, and more interesting, it increased cysteine-protease activity of Der p 1. Our findings support the role of human GSTpi from airways in modulating of Der p 1 cysteine-protease activity, which may have important clinical implications for immune response to this aeroallergen in genetically susceptible individuals.

Identifiants

pubmed: 31229842
pii: S2213-2317(19)30474-4
doi: 10.1016/j.redox.2019.101256
pmc: PMC6597738
pii:
doi:

Substances chimiques

Antigens, Dermatophagoides 0
Arthropod Proteins 0
Isoenzymes 0
GSTP1 protein, human EC 2.5.1.18
Glutathione S-Transferase pi EC 2.5.1.18
Cysteine Endopeptidases EC 3.4.22.-
Dermatophagoides pteronyssinus antigen p 1 EC 3.4.22.-
Cysteine K848JZ4886

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101256

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Drug Metab Rev. 2011 May;43(2):179-93
pubmed: 21351850
Front Pharmacol. 2016 Apr 25;7:107
pubmed: 27199750
Am J Respir Cell Mol Biol. 1995 Apr;12(4):369-78
pubmed: 7695916
J Allergy Clin Immunol. 2009 Feb;123(2):362-8
pubmed: 19135239
J Immunol. 2009 Dec 15;183(12):7958-65
pubmed: 19933866
J Appl Physiol (1985). 1987 Jul;63(1):152-7
pubmed: 3040659
Curr Allergy Asthma Rep. 2018 Mar 20;18(3):20
pubmed: 29557517
Allergy. 2011 Aug;66(8):1088-98
pubmed: 21480927
Science. 2007 Sep 7;317(5843):1393-7
pubmed: 17717153
Clin Exp Allergy. 2011 Mar;41(3):305-11
pubmed: 21121984
Curr Mol Med. 2011 Mar;11(2):129-39
pubmed: 21342130
J Allergy Clin Immunol. 2018 Aug;142(2):398-400
pubmed: 29906529
Int J Mol Sci. 2017 May 23;18(6):
pubmed: 28545251
Redox Biol. 2016 Aug;8:375-82
pubmed: 27058114
Clin Exp Allergy. 2002 Oct;32(10):1468-75
pubmed: 12372127
Biochem J. 1984 Jul 1;221(1):33-41
pubmed: 6466318
Int J Mol Sci. 2017 Jun 27;18(7):
pubmed: 28653989
J Biol Chem. 1998 Dec 4;273(49):32554-60
pubmed: 9829991
EMBO J. 1996 Jun 3;15(11):2760-70
pubmed: 8654373
Clin Biochem. 2003 Jun;36(4):283-8
pubmed: 12810157
Biochim Biophys Acta. 2014 Mar;1840(3):1117-24
pubmed: 24291687
J Biol Chem. 2007 Dec 21;282(51):36808-19
pubmed: 17848554
Blood. 2001 Aug 15;98(4):1135-41
pubmed: 11493462
Antioxid Redox Signal. 2012 Jul 15;17(2):375-408
pubmed: 22304503
Biochem Biophys Res Commun. 1996 Apr 5;221(1):59-61
pubmed: 8660343
J Immunol. 2002 Apr 1;168(7):3577-85
pubmed: 11907122
Clin Chim Acta. 1989 Oct 16;184(3):269-78
pubmed: 2611999
Int J Biol Sci. 2015 Apr 02;11(5):546-58
pubmed: 25892962
Chem Biol. 2003 Aug;10(8):677-93
pubmed: 12954327
Clin Exp Allergy. 2001 Feb;31(2):279-94
pubmed: 11251630
Plant Physiol. 2013 Jul;162(3):1311-23
pubmed: 23709667
EMBO J. 1999 Mar 1;18(5):1321-34
pubmed: 10064598
Oncogenesis. 2018 Jan 24;7(1):8
pubmed: 29362397
Chem Biol Interact. 1998 Apr 24;111-112:91-102
pubmed: 9679546
J Mol Biol. 2009 Feb 20;386(2):520-30
pubmed: 19136006
PLoS One. 2013 Aug 23;8(8):e71278
pubmed: 24009658
J Proteomics. 2012 Sep 18;75(17):5449-62
pubmed: 22800641
Antioxid Redox Signal. 2011 Aug 1;15(3):795-815
pubmed: 20969484
J Immunol. 1998 Oct 1;161(7):3645-51
pubmed: 9759888
J Allergy Clin Immunol. 2006 Mar;117(3):571-6
pubmed: 16522455
Mol Pathol. 1998 Aug;51(4):222-4
pubmed: 9893750
Methods Mol Biol. 2018;1747:73-87
pubmed: 29600452
Anal Chem. 1996 Mar 1;68(5):850-8
pubmed: 8779443
Sci Rep. 2017 Feb 15;7:42341
pubmed: 28198394
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13086-91
pubmed: 16916935
Adv Cancer Res. 2014;122:143-75
pubmed: 24974181
Nahrung. 2002 Feb;46(1):2-6
pubmed: 11890048
Carcinogenesis. 1990 Feb;11(2):295-300
pubmed: 2302756
Eur J Immunol. 1996 Dec;26(12):2972-80
pubmed: 8977293
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 15;1019:29-44
pubmed: 26922696
Biochim Biophys Acta. 1994 Mar 16;1205(1):1-18
pubmed: 8142473
Allergy. 2000;55 Suppl 61:15-20
pubmed: 10919500
Allergol Int. 2015 Oct;64(4):304-11
pubmed: 26433526
Anal Biochem. 1977 Oct;82(2):334-41
pubmed: 907137
Int Arch Allergy Appl Immunol. 1987;82(3-4):444-6
pubmed: 3570508
Antioxid Redox Signal. 2011 Mar 15;14(6):1065-77
pubmed: 20799881
Clin Exp Allergy. 2006 Mar;36(3):369-76
pubmed: 16499649
Front Immunol. 2014 Mar 31;5:138
pubmed: 24744761
J Biol Chem. 2006 Mar 17;281(11):6910-23
pubmed: 16293628
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):381-9
pubmed: 12689923
J Mol Cell Biol. 2012 Oct;4(5):316-30
pubmed: 22878263

Auteurs

Juan Carlos López-Rodríguez (JC)

Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.

Juliana Manosalva (J)

Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.

J Daniel Cabrera-García (JD)

Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.

María M Escribese (MM)

Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo CEU, Madrid, Spain.

Mayte Villalba (M)

Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.

Domingo Barber (D)

Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo CEU, Madrid, Spain.

Antonio Martínez-Ruiz (A)

Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address: amartinezruiz@salud.madrid.org.

Eva Batanero (E)

Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain. Electronic address: ebataner@ucm.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH